Diagonal Bio AB (publ) (NGM:DIABIO)
Sweden
· Delayed Price · Currency is SEK 0.0150
+0.0010 (7.14%)
At close: Apr 17, 2025
Diagonal Bio AB Market Cap
Diagonal Bio AB has a market cap or net worth of 18.22 million as of April 17, 2025. Its market cap has increased by 375.87% in one year.
Market Cap
18.22M
Enterprise Value
17.41M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since July 16, 2021, Diagonal Bio AB's market cap has decreased from 139.06M to 18.22M, a decrease of -86.89%. That is a compound annual growth rate of -41.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 18.22M | 173.98% |
| Dec 30, 2024 | 6.65M | -52.86% |
| Dec 29, 2023 | 14.11M | 40.22% |
| Dec 30, 2022 | 10.06M | -87.72% |
| Dec 30, 2021 | 81.97M | -41.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 90.12B |
| Getinge AB | 53.36B |
| Sectra AB | 52.87B |
| Camurus AB | 32.98B |
| Medicover AB | 32.43B |
| Vitrolife AB | 20.98B |
| Bonesupport Holding AB | 20.89B |
| Vimian Group AB | 20.22B |